OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
313958

Lacto Japan Co Ltd

Food Retail & DistributionVerified

Lacto Japan maintains a capital structure with a debt-to-equity ratio of 1.15, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.7, suggesting it can cover short-term obligations but with limited buffer. Despite a negative net cash position after subtracting total debt, the company reported free cash flow of 2.3 billion JPY, which supports operational flexibility. Profitability metrics show a return on equity (ROE) of 13.3% and a return on assets (ROA) of 4.79%, both exceeding the typical thresholds for the Food Retail & Distribution industry. The gross profit margin of 6.72% (12.29 billion JPY gross profit on 182.82 billion JPY revenue) is in line with industry norms, but the operating margin of 3.25% (5.95 billion JPY operating income) suggests room for improvement in cost control. Geographically, Lacto Japan's revenue is concentrated in Japan, with no disclosed international operations. The company's business is segmented into retail and distribution, with no further breakdown provided in the available data. This concentration may expose the company to domestic economic and regulatory risks. The company's growth trajectory is modest, with no specific revenue growth rates provided in the latest financial data. Analysts have assigned a mean recommendation of 2.00, indicating a "buy" rating, with a consensus price target of 4,100.00 JPY. This suggests a neutral to slightly positive outlook for the near term. Risk factors include a medium liquidity risk due to the negative net cash position and a current ratio that, while acceptable, does not provide a strong buffer against short-term obligations. The company's debt load, particularly long-term debt of 37.15 billion JPY, could become a concern if interest rates rise or if cash flow becomes constrained. However, the dilution risk is assessed as low, with no significant dilution expected in the near term. Recent events include the publication of the latest financial data, which shows a negative operating cash flow of 268 million JPY. This may indicate challenges in managing working capital or a strategic investment in inventory or receivables. The company's capital expenditure of 1.525 billion JPY suggests ongoing investment in infrastructure or expansion.

30-day price · 3139(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyLacto Japan Co Ltd
Ticker3139.T
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Lacto Japan Co Ltd operates in the Food & Drug Retailing industry, primarily generating revenue through the retail and distribution of food and drug products.

Classification. Lacto Japan is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a classification confidence of 0.92.

Lacto Japan maintains a capital structure with a debt-to-equity ratio of 1.15, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.7, suggesting it can cover short-term obligations but with limited buffer. Despite a negative net cash position after subtracting total debt, the company reported free cash flow of 2.3 billion JPY, which supports operational flexibility. Profitability metrics show a return on equity (ROE) of 13.3% and a return on assets (ROA) of 4.79%, both exceeding the typical thresholds for the Food Retail & Distribution industry. The gross profit margin of 6.72% (12.29 billion JPY gross profit on 182.82 billion JPY revenue) is in line with industry norms, but the operating margin of 3.25% (5.95 billion JPY operating income) suggests room for improvement in cost control. Geographically, Lacto Japan's revenue is concentrated in Japan, with no disclosed international operations. The company's business is segmented into retail and distribution, with no further breakdown provided in the available data. This concentration may expose the company to domestic economic and regulatory risks. The company's growth trajectory is modest, with no specific revenue growth rates provided in the latest financial data. Analysts have assigned a mean recommendation of 2.00, indicating a "buy" rating, with a consensus price target of 4,100.00 JPY. This suggests a neutral to slightly positive outlook for the near term. Risk factors include a medium liquidity risk due to the negative net cash position and a current ratio that, while acceptable, does not provide a strong buffer against short-term obligations. The company's debt load, particularly long-term debt of 37.15 billion JPY, could become a concern if interest rates rise or if cash flow becomes constrained. However, the dilution risk is assessed as low, with no significant dilution expected in the near term. Recent events include the publication of the latest financial data, which shows a negative operating cash flow of 268 million JPY. This may indicate challenges in managing working capital or a strategic investment in inventory or receivables. The company's capital expenditure of 1.525 billion JPY suggests ongoing investment in infrastructure or expansion.
Key takeaways
  • Lacto Japan maintains a moderate debt-to-equity ratio of 1.15, indicating a balanced capital structure.
  • The company's ROE of 13.3% and ROA of 4.79% suggest strong profitability relative to industry norms.
  • Despite a negative net cash position, the company reported free cash flow of 2.3 billion JPY, supporting operational flexibility.
  • Analysts have assigned a "buy" rating with a consensus price target of 4,100.00 JPY, indicating a neutral to slightly positive outlook.
  • The company's liquidity risk is assessed as medium, with a current ratio of 1.7 and a negative net cash position after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$182.82B
Gross profit$12.29B
Operating income$5.95B
Net income$4.32B
R&D
SG&A
D&A
SBC
Operating cash flow-$268.0M
CapEx-$1.52B
Free cash flow$2.31B
Total assets$90.21B
Total liabilities$57.76B
Total equity$32.45B
Cash & equivalents$10.16B
Long-term debt$37.15B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$32.45B
Net cash-$27.00B
Current ratio1.7
Debt/Equity1.1
ROA4.8%
ROE13.3%
Cash conversion-6.0%
CapEx/Revenue-0.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
Metric3139Activity
Op margin3.3%2.8% medp25 0.9% · p75 5.9%above median
Net margin2.4%1.8% medp25 0.3% · p75 3.6%above median
Gross margin6.7%24.1% medp25 13.8% · p75 31.4%bottom quartile
CapEx / revenue-0.8%-2.0% medp25 -3.8% · p75 -1.0%top quartile
Debt / equity115.0%56.0% medp25 14.0% · p75 113.8%top quartile
Observations
IR observations
Mean price target4,100.00 JPY
Median price target4,100.00 JPY
High price target4,100.00 JPY
Low price target4,100.00 JPY
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate347.51 JPY
Last actual EPS433.16 JPY
Source: analysis-pipeline (hybrid)Generated: 2026-05-22 04:33 UTCJob: a4cdc718